Sónia Siquenique is a PhD student at the Institute for Research and Innovation in Health (i3S) (Porto, Portugal), in collaboration with Karolinska Institutet (Stockholm, Sweden) and the Technion Israel Institute of Technology (Haifa, Israel), supervised by Prof. Bruno Sarmento and Prof. Avi Schroeder. Her current research focuses on the targeted delivery of  lipid-based particles for type 2 diabetes treatment while exploring the potential of FcRn-targeted moieties. During her PhD, she carried out a 7-month doctoral secondment at Karolinska Institutet (Stockholm, Sweden) and another secondment at Technion Israel Institute of Technology (Haifa, Israel). Since 2021 she has been gaining experience in developing specialized carriers for bioactive compound delivery. She holds a MSc degree in Biopharmaceutical Sciences from the Faculty of Pharmacy of the University of Lisbon (2021) and a BSc degree in Biochemistry from the University of Évora (2018). She developed her master dissertation at iMed.ULisboa-Research Institute for Medicines (Lisbon) under the supervision of Dr. Susana Solá and co-supervision of Dr. Cecília Rodrigues. She worked for two years as a contracted researcher in the Department of Formulations and Process Development at InnovPlantProtect Collaborative Laboratory (Elvas, Portugal). Throughout her journey, Sónia has also been involved in organizing scientific meetings, recently as member of the Young Scientist Committee of the Controlled Release Society.